IPP Bureau
Aster DM Healthcare reports Q4 FY23 consolidated profit at Rs. 170.77 Cr
By IPP Bureau - May 26, 2023
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr
By IPP Bureau - May 26, 2023
The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023
Ministry of Minority Affairs supports development of unani medicine system
By IPP Bureau - May 26, 2023
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Lupin Diagnostics Launches Satellite Laboratory in Vijayawada
By IPP Bureau - May 26, 2023
Continues to Expand its Presence in South India
Lincoln Pharmaceuticals posts FY23 PAT at Rs. 72.90 Cr
By IPP Bureau - May 26, 2023
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
Mandaviya addresses 76th World Health Assembly
By IPP Bureau - May 25, 2023
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
By IPP Bureau - May 25, 2023
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
JB Pharma records revenue growth of 22% to Rs. 762 Cr
By IPP Bureau - May 25, 2023
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
GenWorks launches FenomPro breath analyser
By IPP Bureau - May 25, 2023
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
Oncodesign Services and Veritas In Silico jointly to develop mRNA-targeted small molecule drugs
By IPP Bureau - May 25, 2023
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Tata 1mg-backed 5C Network launches diagnostics-on-demand platform Prodigi PASS
By IPP Bureau - May 24, 2023
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
Lonza launches TheraPEAK T-VIVO cell culture medium to accelerate cell therapy development
By IPP Bureau - May 24, 2023
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
Neutec introduces the oCelloscope automated microbial live-cell imaging technology
By IPP Bureau - May 24, 2023
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi
By IPP Bureau - May 24, 2023
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
By IPP Bureau - May 24, 2023
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
